BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 15127232)

  • 1. Pharmacokinetics and pharmacodynamics of protein-unbound docetaxel in cancer patients.
    Minami H; Kawada K; Sasaki Y; Igarashi T; Saeki T; Tahara M; Itoh K; Fujii H
    Cancer Sci; 2006 Mar; 97(3):235-41. PubMed ID: 16542221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of weekly docetaxel in patients with advanced cancer.
    Slaviero KA; Clarke SJ; McLachlan AJ; Blair EY; Rivory LP
    Br J Clin Pharmacol; 2004 Jan; 57(1):44-53. PubMed ID: 14678339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutropenia and docetaxel exposure in metastatic castration-resistant prostate cancer patients: A meta-analysis and evaluation of a clinical cohort.
    de Vries Schultink AHM; Crombag MBS; van Werkhoven E; Otten HM; Bergman AM; Schellens JHM; Huitema ADR; Beijnen JH
    Cancer Med; 2019 Apr; 8(4):1406-1415. PubMed ID: 30802002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacoethnicity of docetaxel-induced severe neutropenia: integrated analysis of published phase II and III trials.
    Yano R; Konno A; Watanabe K; Tsukamoto H; Kayano Y; Ohnaka H; Goto N; Nakamura T; Masada M
    Int J Clin Oncol; 2013 Feb; 18(1):96-104. PubMed ID: 22095245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904).
    Kudoh S; Takeda K; Nakagawa K; Takada M; Katakami N; Matsui K; Shinkai T; Sawa T; Goto I; Semba H; Seto T; Ando M; Satoh T; Yoshimura N; Negoro S; Fukuoka M
    J Clin Oncol; 2006 Aug; 24(22):3657-63. PubMed ID: 16877734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of oral topotecan in advanced non-small cell lung cancer.
    White SC; Cheeseman S; Thatcher N; Anderson H; Carrington B; Hearn S; Ross G; Ranson M
    Clin Cancer Res; 2000 Mar; 6(3):868-73. PubMed ID: 10741709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-line chemotherapy with a modified schedule of docetaxel in elderly patients with advanced-stage non-small-cell lung cancer.
    Tibaldi C; Bernardini I; Chella A; Russo F; Vasile E; Malventi M; Falcone A
    Clin Lung Cancer; 2006 May; 7(6):401-5. PubMed ID: 16800966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II study of combination chemotherapy with docetaxel and carboplatin for elderly patients with advanced non-small cell lung cancer.
    Kim HJ; Kim TG; Lee HJ; Kim JH; Lim BH; Seo JW; Kang EM; Lee BU; Ahn YM; Roh YH; Nam SH; Kim BS
    Lung Cancer; 2010 May; 68(2):248-52. PubMed ID: 19647333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docetaxel and cyclooxygenase-2 inhibition with celecoxib for advanced non-small cell lung cancer progressing after platinum-based chemotherapy: a multicenter phase II trial.
    Nugent FW; Mertens WC; Graziano S; Levitan N; Collea R; Gajra A; Marshall J; McCann J
    Lung Cancer; 2005 May; 48(2):267-73. PubMed ID: 15829328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and pharmacokinetic study of docetaxel in elderly non-small-cell lung cancer patients.
    Takigawa N; Segawa Y; Kishino D; Fujiwara K; Tokuda Y; Seki N; Shinkai T; Watanabe Y; Hiraki S; Kozuki T; Gemba K; Tabata M; Kiura K; Ueoka H; Tanimoto M
    Cancer Chemother Pharmacol; 2004 Sep; 54(3):230-6. PubMed ID: 15127232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docetaxel administration schedule: from fever to tears? A review of randomised studies.
    Engels FK; Verweij J
    Eur J Cancer; 2005 May; 41(8):1117-26. PubMed ID: 15911234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential for improvement of docetaxel-based chemotherapy: a pharmacological review.
    Engels FK; Sparreboom A; Mathot RA; Verweij J
    Br J Cancer; 2005 Jul; 93(2):173-7. PubMed ID: 16012521
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.